Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)Neoplasm Metastasis, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, neoplasmRecruitingPhase 1 / Phase 22026-10-05NCT07193511

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Avenzo Therapeutics, Inc.4

15 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Avenzo Therapeutics Recruiting SiteOklahoma CityUnited States1
Avenzo Therapeutics Recruiting SiteIrvingUnited States1
Avenzo Therapeutics Recruiting SiteSan FranciscoUnited States1
Avenzo Therapeutics Recruiting SiteNew YorkUnited States1
Avenzo Therapeutics Recruiting SiteMyrtle BeachUnited States1
Avenzo Therapeutics Recruiting SiteNashvilleUnited States2
Avenzo Therapeutics Recruiting SiteTampaUnited States4
Avenzo Therapeutics Recruiting SiteBostonUnited States1
Avenzo Therapeutics Recruiting SiteHoustonUnited States2
Avenzo Therapeutics Recruiting SiteChapel HillUnited States1
Avenzo Therapeutics Recruiting SiteClevelandUnited States3
Avenzo Therapeutics Recruiting SiteAustinUnited States1
Avenzo Therapeutics Recruiting SiteOrlandoUnited States3
Avenzo Therapeutics Recruiting SiteAuroraUnited States1
Avenzo Therapeutics Recruiting SiteNew HavenUnited States2